Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Pain
Interventions
DRUG:
Oxymorphone Extended Release
Sponsor
Endo Pharmaceuticals